Literature DB >> 16431947

Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.

Tiina Sepp1, Jane C Khan, Deborah A Thurlby, Humma Shahid, David G Clayton, Anthony T Moore, Alan C Bird, John R W Yates.   

Abstract

PURPOSE: The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
METHODS: A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
RESULTS: The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
CONCLUSIONS: The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431947     DOI: 10.1167/iovs.05-1143

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  56 in total

1.  Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.

Authors:  Juan Liu; Purushottam Jha; Valeriy V Lyzogubov; Ruslana G Tytarenko; Nalini S Bora; Puran S Bora
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

Review 2.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

3.  Multimodal assessment of microscopic morphology and retinal function in patients with geographic atrophy.

Authors:  Athanasios Panorgias; Robert J Zawadzki; Arlie G Capps; Allan A Hunter; Lawrence S Morse; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-26       Impact factor: 4.799

4.  Reconsidering the connection between vitamin D levels and age-related macular degeneration.

Authors:  S Golan; V Shalev; G Treister; G Chodick; A Loewenstein
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

Review 5.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

6.  Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.

Authors:  Digna R Velez Edwards; Paul Gallins; Monica Polk; Juan Ayala-Haedo; Stephen G Schwartz; Jaclyn L Kovach; Kylee Spencer; Gaofeng Wang; Anita Agarwal; Eric A Postel; Jonathan L Haines; Margaret Pericak-Vance; William K Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

7.  Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Barbara E K Klein; Ronald Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Ronald Klein
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

8.  Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration.

Authors:  Dimitra I Marioli; Nikolaos Pharmakakis; Angeliki Deli; Ioannis Havvas; Ioannis K Zarkadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-30       Impact factor: 3.117

9.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

10.  Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study.

Authors:  Periasamy Sundaresan; Praveen Vashist; Ravilla D Ravindran; Ashwini Shanker; Dorothea Nitsch; Bareng A S Nonyane; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.